Immuno-oncology is a young and growing field in cancer therapy. It stimulates immune system to target and attack the tumor or inhibiting the immune response. Recent findings in cancer immunotherapy has revealed that the immune system can control many cancers across various histologies, producing durable responses in a way which not seen with many small molecule drugs. Advances in understanding the role and molecular mechanisms of immunotherapy are revolutionizing clinical practice in cancer treatment. Immunotherapy is being intensively explored with the aim of improving primary response rates or prolonging overall survival. The purpose of this chapter is to review the different aspect of immunotherapy including blockade of immunological che...
Tumors employ strategies to escape immune control. The principle aim of most cancer immunotherapies ...
Immunotherapy is a method of cancer treatment that uses the patient's immune system to attack the tu...
Immunotherapy has substantial attention in oncology due to the success of CTLA-4 and PD-1 inhibitors...
The concept of immunological surveillance, a monitoring process in which the immune system detects a...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
Cancer immunotherapy is demonstrating impressive clinical benefit in different malignancies and clin...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Tumors employ strategies to escape immune control. The principle aim of most cancer immunotherapies ...
Immunotherapy is a method of cancer treatment that uses the patient's immune system to attack the tu...
Immunotherapy has substantial attention in oncology due to the success of CTLA-4 and PD-1 inhibitors...
The concept of immunological surveillance, a monitoring process in which the immune system detects a...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
In the cancer therapy realm, concepts of immunotherapy rose as a response to emerging adverse effect...
Cancer immunotherapy is demonstrating impressive clinical benefit in different malignancies and clin...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Given the high, and rapidly increasing, incidence of cancer coupled with the enormous cost burden as...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Cancer is one of the leading causes of death: in the year 2007 8 million people died from cancer and...
Tumors employ strategies to escape immune control. The principle aim of most cancer immunotherapies ...
Immunotherapy is a method of cancer treatment that uses the patient's immune system to attack the tu...
Immunotherapy has substantial attention in oncology due to the success of CTLA-4 and PD-1 inhibitors...